Dr. Weldy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-498-6205
Summary
- Dr. Chad Weldy is a cardiologist and a faculty member (Instructor) within the Division of Cardiovascular Medicine and the Stanford Center for Inherited Cardiovascular Disease. He received his M.D. from Duke University School of Medicine and completed his internal medicine internship, residency, and cardiology fellowship at Stanford University as a member of the Stanford Translational Investigator Program (TIP) where he conducted research within the lab of Dr. Thomas Quertermous focused on epigenetics, RNA editing, and genetic mechanisms of disease. Prior to entering medical school, he received his Ph.D. from the University of Washington and completed a postdoctoral fellowship with the University of Washington, Division of Cardiology where he conducted basic science research investigations within the fields of cardiovascular biology, redox biology, toxicology, and epigenetics. Dr. Weldy has a clinical expertise within the field of inherited cardiomyopathies where he treats patients and families within Stanford’s Center for Inherited Cardiovascular Disease (SCICD). As a physician-scientist, Dr. Weldy works to better understand human genetics, epigenetics, and transcriptional regulation in cardiovascular disease. Dr. Weldy has received funding through an NIH/NHLBI K08 Clinical Scientist Research Career Development Award, an American Heart Association Career Development Award (CDA), an F32 Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship award, and an NIH Loan Repayment Award on his work focused on the genetic, epigenetic, and RNA editing mechanisms of vascular disease. Within Stanford, Dr. Weldy has been the recipient of the Gerald Reaven Award for Basic Science from the Division of Cardiovascular Medicine, he has been inducted into AOA from the Stanford School of Medicine, and he was the recipient for the Timothy F. Beckett Jr. Award for Best Clinical Teaching from the Department of Medicine.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2019 - 2023
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2018 - 2019
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2017 - 2018
- Duke University School of MedicineClass of 2017
- University of Washington School of MedicinePost-Doctoral Fellowship, 2012 - 2014
- University of WashingtonPhD, Toxicology, 2007 - 2012
Certifications & Licensure
- CA State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- K08 Mentored Clinician Scientist Career Development Award NIH/NHLBI, 2023
- AHA Career Development Award American Heart Association, 2023
- Timothy F. Beckett Jr. Award for Best Clinical Teaching by a Medicine Fellow Stanford University School of Medicine, 2021
- Join now to see all
Publications & Presentations
PubMed
- 28 citationsHeterozygosity in the glutathione synthesis gene Gclm increases sensitivity to diesel exhaust particulate induced lung inflammation in miceChad S. Weldy, Charles L. White, Hui Wen Wilkerson, Timothy V. Larson, James A. Stewart
Inhalation Toxicology. 2011-10-03 - 21 citationsThe Glutathione Synthesis Gene Gclm Modulates Amphiphilic Polymer-Coated CdSe/ZnS Quantum Dot–Induced Lung Inflammation in MiceLisa A. McConnachie, Dianne Botta, Charles L. White, Chad S. Weldy, Hui Wen Wilkerson
Plos One. 2013-05-27 - 36 citationsTowards precision medicine in heart failureChad S. Weldy, Euan A. Ashley
Nature Reviews. Cardiology. 2021-06-09
Press Mentions
- Ozempic: GLP-1 Drugs May Help Prevent 34,000 Heart Attacks and Strokes Per YearSeptember 20th, 2024
- Wegovy’s Heart Benefits Due to More Than Weight Loss, Novo SaysNovember 13th, 2023
- Wegovy’s Coronary Heart Advantages on Account of Greater Than Weight Reduction, Novo SaysNovember 13th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: